The global alpha thalassemia market is experiencing significant growth due to increasing awareness regarding inherited blood disorders, advancements in genetic diagnostics, and the development of innovative treatment approaches. Alpha thalassemia is a hereditary blood disorder caused by reduced or absent production of alpha-globin chains, leading to anemia and other serious health...

China induced pluripotent stem cells market size and trajectory — the comprehensive commercial market for iPSC research tools, banking services, drug discovery applications, and clinical cell therapy products in China — represents one of Asia's most strategically important emerging biotechnology markets, with the China Induced Pluripotent Stem Cells Market reflecting the market's...

Executive Summary Thalassemia Market Opportunities by Size and Share The global thalassemia market size was valued at USD 986.00 million in 2024 and is projected to reach USD 3,232.52 million by 2032, with a CAGR of 16.00% during the forecast period of 2025 to 2032.  An international Thalassemia Market report lends a hand to identify how the market is going to perform...